Plasmapheresis Market Progress & Manufacturer Contribution Highlighted until 2026
Verfasser: ashwani_kailiya on Wednesday, 26 June 2019Prevalence of autoimmune diseases has led to an upsurge in demand for plasmapheresis globally. Growing need for conducting an extracorporeal therapy is further expected to impact growth of the global autoimmune diseases market positively. Some of the autoimmune diseases that increasingly fuel demand for plasmapheresis include type 1 diabetes, celiac disease, rheumatoid arthritis, temporal arteritis and lupus. In a recently published report, CDC stated that 9.4% of the population in the U.S. have diabetes, and 30.3 million globally. Plasmapheresis is also used for treatment of various forms of neurotherapy and sickle cell diseases. According to Fact.MR, the global plasmapheresis market is expected to represent a value of over US$ 1,500 Mn by the end of 2026.
Ask for Free Sample Report at – https://www.factmr.com/connectus/sample?flag=S&rep_id=351
Treatment of the Autoimmune Diseases to Boost Demand